Oncolytic Immunotherapy

被引：11
|
作者：
Hennessy, Morgan L. [1 ]
Bommareddy, Praveen K. [2 ]
Boland, Genevieve [1 ]
Kaufman, Howard L. [1 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Div Surg Oncol, 55 Fruit St,Yawkey 7B, Boston, MA 02114 USA
[2] Rutgers State Univ, Sch Grad Studies, Grad Sch Biomed Sci, 195 Little Albany St, New Brunswick, NJ 08901 USA
[3] Replimune Inc, Woburn, MA 01801 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2019年 / 28卷 / 03期
关键词：
Cancer; Immunogenic cell death; Immunotherapy; Intratumoral; Oncolytic virus; Treatment; PEXA-VEC JX-594; TALIMOGENE LAHERPAREPVEC; LENTIGO MALIGNA; OPEN-LABEL; CANCER; VIRUS; TRIAL; 1ST; IMIQUIMOD; MELANOMA;
D O I：
10.1016/j.soc.2019.02.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Oncolytic viruses are naturally occurring, or genetically engineered viruses that can be administered via intralesional injections or intravenously to induce cell death in tumor cells and activate antitumor immune responses. This review summarizes several oncolytic viruses in preclinical and clinical trials, describes challenges in clinical implementation, and important areas of future investigation.
引用
收藏
页码：419 / +
页数：13
相关论文
共 50 条
  • [41] Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses
    Scott, Eleanor M.
    Duffy, Margaret R.
    Freedman, Joshua D.
    Fisher, Kerry D.
    Seymour, Leonard W.
    MACROMOLECULAR BIOSCIENCE, 2018, 18 (01)
  • [42] Cationic Spherical Polypeptides with Immunogenic Cell Death Inducing Activity for Oncolytic Immunotherapy
    Guo, Zhihui
    Huang, Tianze
    Yin, Renyong
    Tian, Yongchang
    Wan, Pengqi
    Yi, Xuan
    Li, Gao
    Zhang, Peng
    Xiao, Chunsheng
    Chen, Xuesi
    CCS CHEMISTRY, 2025, 7 (01): : 180 - 193
  • [43] Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
    Zhang, Yalei
    Li, Ye
    Chen, Kun
    Qian, Ling
    Wang, Peng
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [44] Tackling HLA Deficiencies Head on with Oncolytic Viruses
    Fisher, Kerry
    Hazini, Ahmet
    Seymour, Leonard W.
    CANCERS, 2021, 13 (04) : 1 - 14
  • [45] Tanapoxvirus: From discovery towards oncolytic immunovirotherapy
    Suryawanshi, Yogesh R.
    Zhang, Tiantian
    Razi, Farzad
    Essani, Karim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 708 - 712
  • [46] Measles Virus as an Oncolytic Immunotherapy
    Engeland, Christine E.
    Ungerechts, Guy
    CANCERS, 2021, 13 (03) : 1 - 19
  • [47] Oncolytic Immunotherapy for Treatment of Cancer
    Tsun, A.
    Miao, X. N.
    Wang, C. M.
    Yu, D. C.
    PROGRESS IN CANCER IMMUNOTHERAPY, 2016, 909 : 241 - 283
  • [48] A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Barker, Christopher A.
    DAngelo, Sandra P.
    Wasilewski, Gloria
    Steckler, Alexa M.
    Lian, Ming
    Zhang, Zhigang
    Chapman, Paul B.
    Shoushtari, Alexander N.
    Ariyan, Charlotte E.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [49] Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?
    Davola, Maria Eugenia
    Mossman, Karen Louise
    ONCOIMMUNOLOGY, 2019, 8 (06):
  • [50] Assessing the impact of immunotherapy on oncolytic virotherapy in the treatment of cancer
    Omer, Salaheldin
    Mambili-Mamboundou, Hermane
    JOURNAL OF APPLIED MATHEMATICS AND COMPUTING, 2024, 70 (05) : 4793 - 4825
12345